Published in Bone Marrow Transplant on August 04, 2014
Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach. Biol Blood Marrow Transplant (2015) 0.83
Interaction of natural killer cells with neutrophils exerts a significant antitumor immunity in hematopoietic stem cell transplantation recipients. Cancer Med (2015) 0.76
The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease. Blood (2016) 0.75
1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant (2005) 19.83
Graft-versus-host disease. Lancet (2009) 8.78
Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet (2008) 5.53
A biomarker panel for acute graft-versus-host disease. Blood (2008) 3.83
Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol (2012) 3.24
Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc (1974) 2.95
Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst (1974) 2.22
Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst (1955) 2.16
Modification of irradiation injury in mice and guinea pigs by bone marrow injections. J Natl Cancer Inst (1951) 2.13
Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma. Bone Marrow Transplant (2008) 1.72
Keratinocyte dysplasia: an usual finding after transplantation or chemotherapy. J Cutan Pathol (2002) 1.60
The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol (1977) 1.58
Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol (1979) 1.55
Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med (1997) 1.41
'A rose by any other name would smell as sweet', or would it? Bone Marrow Transplant (2013) 1.41
Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res (1971) 1.32
Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation. Arch Dermatol (1987) 1.26
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance. Bone Marrow Transplant (2007) 1.12
Male DNA in female donor apheresis and CD34-enriched products. Blood (2003) 1.09
Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome. Biol Blood Marrow Transplant (2006) 1.08
Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors. Lancet (1979) 1.04
The clinical spectrum of acute graft-versus-host disease. Semin Hematol (2006) 1.04
The cutaneous histopathology of chemotherapeutic reactions. J Cutan Pathol (1993) 1.03
Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases. Mod Pathol (2010) 1.00
Graft-versus-host disease in recipients of syngeneic bone marrow. Lancet (1980) 0.97
Spontaneous autologous graft-versus-host disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts. Biol Blood Marrow Transplant (2011) 0.97
Value of skin biopsies in assessing prognosis and progression of acute graft-versus-host disease. Am J Surg Pathol (1997) 0.95
Subacute radiation dermatitis: a histologic imitator of acute cutaneous graft-versus-host disease. J Am Acad Dermatol (1989) 0.89
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma. Biol Blood Marrow Transplant (2007) 0.88
Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia. Ann Intern Med (1982) 0.88
Acute cutaneous eruptions after marrow ablation: roses by other names? J Cutan Pathol (1994) 0.83
Cutaneous pathology following etoposide therapy. J Cutan Pathol (1987) 0.82
Murine syngeneic graft-versus-host disease is responsive to broad-spectrum antibiotic therapy. J Immunol (2011) 0.80
Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery. Arch Dermatol (1993) 0.79
Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation. Blood (2004) 0.78
Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period. Biol Blood Marrow Transplant (2012) 0.77
Cutaneous eruptions of lymphocyte recovery. Arch Dermatol (1989) 0.77
What does MRD in leukemia really mean? Leukemia (2013) 1.06
JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy. Leukemia (2016) 0.85
Measurable residual disease testing in acute myeloid leukaemia. Leukemia (2017) 0.83
Should persons with acute myeloid leukemia have a transplant in first remission? Leukemia (2014) 0.82
Measureable residual disease (MRD): much ado about nothing? Bone Marrow Transplant (2014) 0.79
Arrhythmias in the setting of hematopoietic cell transplants. Bone Marrow Transplant (2015) 0.76
Engraftment syndrome, the Emperor's new clothes and the artist formerly known as Prince. Bone Marrow Transplant (2015) 0.76
Transmission of CML or of t(9; 22) and BCR/ABL? They are not the same. Bone Marrow Transplant (2015) 0.75
Transplants for MDS and quality-of-life. But whose quality-of-life? Bone Marrow Transplant (2016) 0.75
Phase-1/-2 study of pomalidomide in chronic GvHD. Bone Marrow Transplant (2015) 0.75
What is the (p-) value of the P-value? Leukemia (2016) 0.75
What is the P-value anyway? Bone Marrow Transplant (2016) 0.75
How can we know if new drugs are effective in myeloproliferative neoplasm-associated myelofibrosis? Leukemia (2016) 0.75
Haematopoietic cell transplants in Latin America. Bone Marrow Transplant (2016) 0.75
Reduced-intensity transplants, conventional transplants or chemotherapy for acute myeloid leukemia in 1st remission: who knows; ask your wife? Leukemia (2015) 0.75
Early and late graft-failure after transplants. Bone Marrow Transplant (2015) 0.75
Reply to Passamonti et al: ruxolitinib and survival improvement in patients with myelofibrosis. Leukemia (2014) 0.75
MYC is a positive regulator of choline metabolism and impedes mitophagy-dependent necroptosis in diffuse large B-cell lymphoma. Blood Cancer J (2017) 0.75
One or two umbilical cord blood cell units? Caveat emptor. Bone Marrow Transplant (2017) 0.75
How good are we at predicting the fate of someone with acute myeloid leukaemia? Leukemia (2017) 0.75
John Leslie Fahey 1924-2014. Bone Marrow Transplant (2014) 0.75
Thirty years of Bone Marrow Transplantation. Bone Marrow Transplant (2016) 0.75